A Review of Completed and Ongoing Complement Inhibitor Trials for Geographic Atrophy Secondary to Age-Related Macular Degeneration

A Review of Completed and Ongoing Complement Inhibitor Trials for Geographic Atrophy Secondary to Age-Related Macular Degeneration

Age-related macular degeneration (AMD) is a leading cause of irreversible blindness among older adults in the Western world. While therapies exist for patients with exudative AMD, there are currently no approved therapies for non-exudative AMD and its advanced form of geographic atrophy (GA). The di...

Full description

Bibliographic Details
Main Authors: Omar A. Halawa, Jonathan B. Lin, Joan W. Miller, Demetrios G. Vavvas
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Journal of Clinical Medicine
Subjects:
complement inhibitors
age-related macular degeneration
AMD
exudation
exudative AMD
wet AMD
Online Access:https://www.mdpi.com/2077-0383/10/12/2580

Internet

https://www.mdpi.com/2077-0383/10/12/2580

Similar Items